Government health advisers sharply criticized a closely watched Alzheimer's drug on Friday, concluding there wasn't enough evidence that the experimental drug slowed the brain-destroying disease.
Nov 7, 2020
0
41
A new study published in the Journal of the National Cancer Institute is the first to examine the opinions and experiences of clinical oncologists working at a major medical center on the Federal Right to Try (RTT) law.
Sep 22, 2020
0
1
Scientists at the University of Pittsburgh School of Medicine say they have discovered a super-potent molecule that was "highly effective" at preventing and treating COVID-19 when tested in mice and hamsters.
Sep 21, 2020
0
3
Dr Stephen Hahn, the commissioner of the US Food and Drug Administration, apologized Monday after misrepresenting a key statistic on how effective blood plasma is for treating COVID-19 when announcing an emergency approval ...
Aug 25, 2020
0
84
The World Health Organization on Monday cautioned that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy, voicing the concern as a U.S. boost for the treatment ...
Aug 24, 2020
0
7
An extensive international study led by Prof. Illana Gozes of Tel Aviv University's Department of Human Molecular Genetics and Biochemistry found deposits of the tau protein typically found in Alzheimer's patients in tissues ...
Jul 28, 2020
0
34
An international group of researchers have discovered that inhibiting AHR (aryl hydrocarbon receptor)—a protein with roles in regulating immunity, stem cell maintenance and cellular differentiation—enables the immune ...
Jul 20, 2020
0
194
Lopinavir is a drug against HIV; hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs were regarded as potential agents in the fight against the coronavirus SARS-CoV-2. A research group from ...
Jul 13, 2020
0
272
An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a phase 1/phase 2 clinical trial conducted at Washington University School of Medicine in St. Louis, Massachusetts ...
Jul 8, 2020
0
76
Although the spreading SARS-CoV-2 coronavirus usually causes only mild respiratory symptoms, the COVID-19 disease progresses so severely in around five percent of those affected that acute respiratory distress can occur. ...
Jun 22, 2020
0
31
